Laura Zanaboni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone.
Journal: Haematologica
Published: December 31, 2016
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
Journal: Endocrine
Published: August 06, 2015
A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
Journal: Annals of hematology
Published: May 27, 2014
Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients.
Journal: Blood cells, molecules & diseases
Published: January 28, 2014
Thalassemic osteopathy: a new marker of bone deposition.
Journal: Blood cells, molecules & diseases
Published: May 21, 2013
Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
Journal: Annals of hematology
Published: February 10, 2012
An update on iron chelation therapy.
Journal: Blood transfusion = Trasfusione del sangue
Published: January 19, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026